Asthma: Principles of treatment

Allergy and Asthma Proceedings

Volumn 33, Issue SUPPL. 1, 2012, Pages

  Carr, Tara F ^a   Peters, Anju T ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE DIPROPIONATE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; BUDESONIDE PLUS FORMOTEROL; CICLESONIDE; CORTICOSTEROID; CROMOGLYCATE DISODIUM; FLUTICASONE; FLUTICASONE PROPIONATE PLUS SALMETEROL; FORMOTEROL FUMARATE PLUS MOMETASONE FUROATE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LEVALBUTEROL; METHYLPREDNISOLONE; MOMETASONE FUROATE; MONTELUKAST; OMALIZUMAB; PREDNISONE; SALBUTAMOL; THEOPHYLLINE; ZAFIRLUKAST; ZILEUTON;

ALLERGIC ASTHMA; ALLERGIC RHINITIS; AMINOTRANSFERASE BLOOD LEVEL; ASTHMA; BONE DENSITY; CATARACT; COMORBIDITY; DRUG MEGADOSE; EXERCISE INDUCED ASTHMA; FORCED EXPIRATORY VOLUME; GASTROESOPHAGEAL REFLUX; HEART PALPITATION; HOARSENESS; HUMAN; HYPERGLYCEMIA; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNOTHERAPY; LARYNGOPHARYNGEAL REFLUX; LOW DRUG DOSE; LUNG FUNCTION; PEAK EXPIRATORY FLOW; QUALITY OF LIFE; RECURRENT INFECTION; RHINITIS; RHINOSINUSITIS; SHORT SURVEY; SIDE EFFECT; SLEEP APNEA SYNDROME; SMOKING; SUBSTANCE ABUSE; TACHYCARDIA; THRUSH; TREMOR; VOICE CHANGE; WEIGHT GAIN;

EID: 84863206287     PISSN: 10885412     EISSN: 15396304     Source Type: Journal    
DOI: 10.2500/aap.2012.33.3545     Document Type: Short Survey

References (13)

1. Greenberger PA. Asthma. In Patterson's Allergic Diseases, 7th ed. Grammer LC, and Greenberger PA (Eds). Philadelphia, PA: Lippincott, Williams & Wilkins, 333-388, 2009.
2. Shah R, and Saltoun CA. Acute severe asthma (status asthmaticus). Allergy Asthma Proc 33:S47-S50, 2012.
3. Greenberger PA. Allergic bronchopulmonary aspergillosis. Allergy Asthma Proc 33:S61-S63, 2012.
4. Provisional Recommendations for Use of Pneumococcal Vaccines. Centers for Disease Control, October 2008. Available online at www.cdc.gov/vaccines/recs/ provisional/downloads/pneumo-oct-2008-508.pdf.
5. Georgy MS, and Peters AT. Rhinosinusitis. Allergy Asthma Proc. 33:S24 -S27, 2012.
6. National Heart, Lung, and Blood Institute. National asthma education and prevention program. Expert panel report 3: Guidelines for the diagnosis and management of asthma. Summary Report 2007, NIH publication 08-5846, October 2007.
7. Delea TE, Hagiwara M, Stempel DA, and Stanford RH. Adding salmeterol to fluticasone propionate or increasing the dose of fluticasone propionate in patients with asthma. Allergy Asthma Proc 31:211-218, 2010.
8. Nelson HS, Weiss ST, Bleecker ER et al. The Salmeterol Multicenter Asthma Research Trial: A comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol. Chest 129:15-26, 2006. (Pubitemid 43265239)
9. Fuhlbrigge A, Jr RL, Rasouliyan L, et al. Practice patterns for oral corticosteroid burst therapy in the outpatient management of acute asthma exacerbations. Allergy Asthma Proc 33:82-89, 2012.
10. Georgy MS, and Saltoun CA. Allergen immunotherapy: Definition, indication, and reactions. Allergy Asthma Proc 33:S9-S11, 2012.
11. Saltoun CA. Update on efficacy of allergen immunotherapy for allergic rhinitis and asthma. Allergy Asthma Proc 23:370-380, 2002.
12. Cox L, Nelson H, Lockey R, et al. Allergen immunotherapy: A practice parameter third update. J Allergy Clin Immunol 127(suppl):S1-S55, 2011.
13. Humbert M, Beasley R, Ayres J, et al. Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE. Allergy 60:309-316, 2005. (Pubitemid 40293346)